Founded in 2014 and headquartered in Frankfurt, Germany, Aescuvest is a leading European deal-by-deal venture capital boutique focused on Healthtech startups. The firm enables investors to build personalized portfolios by co-investing in carefully selected Healthtech companies. Aescuvest's investment areas include Med-Tech, Health-Tech, Bio-Tech, and Pharma, with a focus on Series A and B funding stages. The firm has facilitated investments in innovative healthcare companies across Europe, with a minimum investment size of €3 million.
Is Aescuvest the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Aescuvest, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Series A, Series B or later
First ticket size
€3,000,000 - €5,000,000
When approaching Aescuvest, founders should highlight how their solution addresses significant unmet needs in healthcare and demonstrate strong clinical validation or regulatory progress. Emphasize scalability across European markets and a clear path to commercialization, as Aescuvest values ventures with tangible traction and cross-border growth potential. Articulate how your team’s expertise and network can accelerate adoption within the complex healthcare ecosystem, and be prepared to discuss co-investment opportunities that align with Aescuvest’s collaborative investment model.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.